| C10AX11 |
C10AX11 mipomersen |
| C10AX12 |
C10AX12 lomitapide |
| C10AX13 |
C10AX13 Evolocumab |
| C10AX14 |
C10AX14 alirocumab |
| C10AX15 |
C10AX15 Bempedoic Acid |
| C10AX16 |
C10AX16 Inclisiran |
| C10B |
C10B Lipid modifying agents, combinations |
| C10BA |
C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents |
| C10BA01 |
C10BA01 lovastatin and nicotinic acid |
| C10BA02 |
C10BA02 simvastatin and ezetimibe |
| C10BA03 |
C10BA03 pravastatin and fenofibrate |
| C10BA04 |
C10BA04 Simvastatin and Fenofibrate |
| C10BA05 |
C10BA05 atorvastatin and ezetimibe |
| C10BA06 |
C10BA06 rosuvastatin and ezetimibe |
| C10BA07 |
C10BA07 Rosuvastatin And Omega-3 Fatty Acids |
| C10BA08 |
C10BA08 Atorvastatin And Omega-3 Fatty Acids |
| C10BA09 |
C10BA09 Rosuvastatin And Fenofibrate |
| C10BX |
C10BX HMG CoA reductase inhibitors, other combinations |
| C10BX01 |
C10BX01 simvastatin and acetylsalicylic acid |
| C10BX02 |
C10BX02 pravastatin and acetylsalicylic acid |
| C10BX03 |
C10BX03 atorvastatin and amlodipine |
| C10BX04 |
C10BX04 simvastatin, acetylsalicylic acid and ramipril |
| C10BX05 |
C10BX05 rosuvastatin and acetylsalicylic acid |
| C10BX06 |
C10BX06 atorvastatin, acetylsalicylic acid and ramipril |
| C10BX07 |
C10BX07 rosuvastatin, amlodipine and lisinopril |
| C10BX08 |
C10BX08 atorvastatin and acetylsalicylic acid |
| C10BX09 |
C10BX09 rosuvastatin and amlodipine |
| C10BX10 |
C10BX10 rosuvastatin and valsartan |
| C10BX11 |
C10BX11 atorvastatin, amlodipine and perindopril |
| C10BX12 |
C10BX12 atorvastatin, acetylsalicylic acid and perindopril |